Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bodd MH"'
Publikováno v:
The Hastings Center report [Hastings Cent Rep] 2024 Mar; Vol. 54 (2), pp. 12-21.
Autor:
Daniels NC; Duke University, Durham, NC, USA., Bodd MH; Duke University School of Medicine, Durham, NC, 27710, USA., Locke SC; Duke Cancer Institute, Durham, NC, USA., LeBlanc TW; Duke University School of Medicine, Durham, NC, 27710, USA. thomas.leblanc@duke.edu.; Duke Cancer Institute, Durham, NC, USA. thomas.leblanc@duke.edu.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Jul 05; Vol. 31 (7), pp. 443. Date of Electronic Publication: 2023 Jul 05.
Autor:
Bodd MH; Duke University, School of Medicine, Durham, NC, USA., McCammon SD; Department of Otolaryngology, Heersink School of Medicine, 1155 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35233, USA. Electronic address: smccammon@uabmc.edu.
Publikováno v:
Otolaryngologic clinics of North America [Otolaryngol Clin North Am] 2023 Apr; Vol. 56 (2), pp. 403-412.
Autor:
Bodd MH; Duke University School of Medicine, Durham, NC, USA., Locke SC; Duke Cancer Institute, Duke University, Durham, NC, USA., Wolf SP; Division of Biostatistics, Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC 27710, USA., Antonia S; Duke Cancer Institute, Duke University, Durham, NC, USA; Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA., Crawford J; Duke Cancer Institute, Duke University, Durham, NC, USA; Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA., Hartman J; Bristol Myers Squibb, Lawrenceville, NJ, USA., Herring KW; Duke Cancer Institute, Duke University, Durham, NC, USA., Ready NE; Duke Cancer Institute, Duke University, Durham, NC, USA; Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA., Stinchcombe TE; Duke Cancer Institute, Duke University, Durham, NC, USA; Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA., Troy JD; Division of Biostatistics, Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC 27710, USA., Williams C; Bristol Myers Squibb, Lawrenceville, NJ, USA., Clarke JM; Duke Cancer Institute, Duke University, Durham, NC, USA; Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA., LeBlanc TW; Duke Cancer Institute, Duke University, Durham, NC, USA; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. Electronic address: thomas.leblanc@duke.edu.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Jan; Vol. 175, pp. 17-26. Date of Electronic Publication: 2022 Nov 21.
Autor:
Bodd MH; Duke University School of Medicine, 8 Searle Center Dr, Durham, NC, 27710, USA. monica.bodd@duke.edu., Daniels NC; Duke University, Durham, NC, USA., Amonoo HL; Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Tate T; Oregon Health and Science University, Portland, OR, USA., Herring KW; Duke Cancer Institute, Durham, NC, USA., LeBlanc TW; Duke Cancer Institute, Durham, NC, USA.; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Dec 27; Vol. 31 (1), pp. 87. Date of Electronic Publication: 2022 Dec 27.
Autor:
Amonoo HL; Department of Psychiatry, Brigham and Women's Hospital.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, and.; Harvard Medical School, Boston, Massachusetts., Daskalakis E; Department of Psychiatry, Brigham and Women's Hospital., Deary EC; Department of Psychiatry, Brigham and Women's Hospital., Bodd MH; Duke University School of Medicine, Durham, North Carolina., Reynolds MJ; Division of Hematology and Oncology, Department of Medicine, and., Nelson AM; Harvard Medical School, Boston, Massachusetts.; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Newcomb R; Division of Hematology and Oncology, Department of Medicine, and., Dhawale TM; Division of Hematology and Oncology, Department of Medicine, and., Yang D; Division of Hematology and Oncology, Department of Medicine, and., Luger SM; Division of Hematology Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Gustin JL; Division of Palliative Medicine, The James Cancer Hospital, Ohio State University, Columbus, Ohio; and., Brunner A; Harvard Medical School, Boston, Massachusetts.; Division of Hematology and Oncology, Department of Medicine, and., Fathi AT; Harvard Medical School, Boston, Massachusetts.; Division of Hematology and Oncology, Department of Medicine, and., LeBlanc TW; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., El-Jawahri A; Harvard Medical School, Boston, Massachusetts.; Division of Hematology and Oncology, Department of Medicine, and.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2022 Oct; Vol. 20 (10), pp. 1116-1123.
Autor:
Amonoo HL; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Bodd MH; Division of Hematology and Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC; and., Reynolds MJ; Division of Hematology and Oncology, Department of Medicine, and., Nelson AM; Harvard Medical School, Boston, MA.; Department of Psychiatry, Massachusetts General Hospital, Boston, MA., Newcomb R; Division of Hematology and Oncology, Department of Medicine, and., Johnson PC; Division of Hematology and Oncology, Department of Medicine, and., Dhawale TM; Division of Hematology and Oncology, Department of Medicine, and., Plotke R; Division of Hematology and Oncology, Department of Medicine, and., Heuer L; Division of Hematology and Oncology, Department of Medicine, and., Gillani S; Division of Hematology and Oncology, Department of Medicine, and., Yang D; Division of Hematology and Oncology, Department of Medicine, and., Deary EC; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA., Daskalakis E; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA., Goldschen L; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA., Brunner A; Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC; and.; Division of Hematology and Oncology, Department of Medicine, and., Fathi AT; Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Department of Medicine, and., LeBlanc TW; Division of Hematology and Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC; and., El-Jawahri A; Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC; and.; Division of Hematology and Oncology, Department of Medicine, and.
Publikováno v:
Blood advances [Blood Adv] 2022 Apr 12; Vol. 6 (7), pp. 2435-2442.
Autor:
Venkatesulu BP; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Mahadevan LS; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Aliru ML; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Yang X; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Bodd MH; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Singh PK; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Yusuf SW; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas., Abe JI; Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas.; Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas., Krishnan S; Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
JACC. Basic to translational science [JACC Basic Transl Sci] 2018 Aug 28; Vol. 3 (4), pp. 563-572. Date of Electronic Publication: 2018 Aug 28 (Print Publication: 2018).